Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

SOP for Handling Carcinogenic and Teratogenic Substances

Posted on By

SOP for Handling Carcinogenic and Teratogenic Substances

Standard Operating Procedure for Safe Handling of Carcinogenic and Teratogenic Substances

1) Purpose

The purpose of this SOP is to establish guidelines for the safe handling, storage, and disposal of carcinogenic and teratogenic substances, ensuring the protection of personnel, the environment, and regulatory compliance.

2) Scope

This SOP applies to all personnel involved in the handling, transportation, storage, and disposal of carcinogenic and teratogenic substances within laboratories, warehouses, and production facilities.

3) Responsibilities

  • Operators: Follow all safety measures and wear appropriate PPE when handling these substances.
  • Supervisors: Monitor handling procedures and ensure safe working conditions.
  • Safety Officers: Conduct risk assessments, provide safety training, and inspect compliance with this SOP.
  • Maintenance Team: Ensure the functionality of ventilation systems and emergency equipment.

4) Procedure

4.1 Identification of Carcinogenic and Teratogenic Substances

  1. Definition:
    • Carcinogenic Substances: Chemicals or agents capable of causing cancer in humans (e.g., benzene, asbestos).
    • Teratogenic Substances: Chemicals that can cause developmental defects in unborn children (e.g., thalidomide, mercury compounds).
  2. less
    Copy code

  3. Material Identification:
    1. Identify these substances through:
      • Labels with GHS hazard symbols (e.g., health hazard pictogram)
      • Safety Data Sheets (SDS), Sections 2 and 11
    2. Ensure all containers are clearly labeled with:
      • Material name
      • Hazard classification (carcinogen/teratogen)
      • Handling precautions
See also  SOP for Documenting and Reporting Near-Miss Incidents

4.2 Safety Measures for Handling

  1. Personal Protective Equipment (PPE):
    1. Wear appropriate PPE, including:
      • Full-body protective suits
      • Chemical-resistant gloves (nitrile,
butyl)
  • Respiratory protection (N95 mask or air-purifying respirators)
  • Safety goggles or full-face shields
  • Inspect PPE for damage before and after use.
  • less
    Copy code

  • Work Practices:
    1. Handle carcinogenic and teratogenic substances in designated areas such as:
      • Fume hoods or ventilated enclosures
      • Biological safety cabinets for powders
    2. Avoid manual handling; use mechanical devices such as pumps or dispensers for liquids.
    3. Prohibit eating, drinking, and smoking in areas where these substances are handled.
  • Transfer Procedures:
    1. Use sealed systems for transferring liquids or gases to minimize exposure.
    2. Prevent spills or splashes by using funnels, spill trays, or transfer pumps.
  • Minimizing Exposure:
    1. Keep exposure times as short as possible.
    2. Monitor air quality regularly to ensure compliance with exposure limits.
  • 4.3 Storage Guidelines

    1. Storage Requirements:
      1. Store carcinogenic and teratogenic substances in designated, labeled, and locked storage cabinets.
      2. Segregate these substances from incompatible chemicals, such as oxidizers or flammable materials.
      3. Ensure storage areas are well-ventilated with no ignition sources nearby.
    2. less
      Copy code

    3. Labeling and Signage:
      1. Post hazard warning signs such as “Danger – Carcinogenic Substances” or “Teratogenic Hazard – Authorized Personnel Only.”
      2. Maintain clear inventory records for stored quantities (Annexure 1).

    4.4 Spill and Emergency Management

    1. Minor Spills:
      1. Alert nearby personnel and restrict access to the area.
      2. Wear full PPE and use spill kits with absorbents designed for carcinogenic and teratogenic chemicals.
      3. Decontaminate the area with appropriate cleaning agents as per SDS recommendations.
    2. less
      Copy code

    3. Major Spills:
      1. Evacuate the area immediately and contact the Safety Officer.
      2. Activate emergency alarms and ventilation systems to reduce vapor exposure.
      3. Call the designated emergency response team for spill cleanup.
    4. Exposure Response:
      1. Skin Contact: Wash affected areas with running water for at least 15 minutes.
      2. Eye Contact: Flush eyes using an emergency eyewash station for 15 minutes.
      3. Inhalation: Move to fresh air and seek medical attention immediately.

    4.5 Waste Disposal

    1. Label waste containers as “Hazardous – Carcinogenic/Teratogenic Waste.”
    2. Dispose of materials in accordance with regulatory requirements (e.g., EPA or local hazardous waste guidelines).
    3. Maintain records of disposal dates, quantities, and methods (Annexure 2: Hazardous Waste Disposal Log).

    4.6 Training and Compliance

    1. Conduct mandatory training for all employees handling carcinogenic and teratogenic substances, covering:
      • Hazard identification and risk minimization
      • Proper handling, storage, and disposal techniques
      • Emergency response procedures
    2. Provide refresher training annually or after any incident.
    3. Maintain training records and ensure compliance during internal audits.

    5) Abbreviations, if any

    • SDS: Safety Data Sheet
    • PPE: Personal Protective Equipment

    6) Documents, if any

    • Hazardous Material Inventory Log
    • Incident Reports
    • Hazardous Waste Disposal Log

    7) Reference, if any

    • OSHA Carcinogen Standard (29 CFR 1910.1450)
    • EPA Hazardous Waste Management Guidelines
    • NIOSH Carcinogen Policy Guidelines

    8) SOP Version

    Version: 1.0

    Annexure

    Template 1: Hazardous Material Inventory Log

     
    Material Name Type (Carcinogen/Teratogen) Quantity Storage Location Date Received Handled By
    Material Name Carcinogen XX Liters/Kg Storage Area 1 DD/MM/YYYY Employee Name

    Template 2: Hazardous Waste Disposal Log

     
    Date Material Name Quantity Disposal Method Disposed By
    DD/MM/YYYY Material Name XX Liters/Kg Incineration/Landfill Employee Name
    See also  SOP for Segregation of Pharmaceutical Waste
    Environment, Health and Safety Tags:Emergency response for hazardous materials incidents, Hazardous materials classification, Hazardous materials compliance audits, Hazardous materials decontamination procedures, Hazardous materials disposal methods, Hazardous materials emergency planning, Hazardous materials emergency response guidebook, Hazardous materials exposure limits, Hazardous materials handling, Hazardous materials handling equipment, Hazardous materials incident command system, Hazardous materials incident reporting, Hazardous materials inventory management, Hazardous materials labeling requirements, Hazardous materials monitoring equipment, Hazardous materials packaging requirements, Hazardous materials placarding requirements, Hazardous materials regulatory agencies, Hazardous materials response team training, Hazardous materials risk assessment, Hazardous materials security plans, Hazardous materials shipping papers, Hazardous materials spill response, Hazardous materials storage guidelines, Hazardous materials training requirements, Hazardous materials transportation regulations, Hazardous materials transportation safety, Personal protective equipment for hazardous materials, Regulatory compliance in hazardous materials management, Safety procedures for hazardous materials

    Post navigation

    Previous Post: Ointments: SOP for Cross-Contamination Prevention During Dispensing – V 2.0
    Next Post: SOP for Manufacturing Process Flow Documentation

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Gels V 2.0
    • Injectables V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version